Normal Pressure Hydrocephalus (NPH) - Secondary: A Comprehensive Medical Guide

Introduction & Overview

Normal Pressure Hydrocephalus (NPH) is a complex neurological condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to ventricular enlargement. Crucially, despite the increased CSF volume, the intracranial pressure (ICP) typically remains within the normal range, at least intermittently. This distinction sets NPH apart from other forms of hydrocephalus where elevated ICP is a hallmark.

While NPH can occur idiopathically (primary NPH), a significant subset of patients develop this condition secondary to identifiable underlying causes. "Normal Pressure Hydrocephalus (NPH) - Secondary" refers to this acquired form of NPH, where the ventricular enlargement and associated neurological symptoms arise as a consequence of a specific insult or disease process affecting the brain's CSF dynamics. Understanding secondary NPH is paramount for accurate diagnosis, timely intervention, and ultimately, improving patient outcomes. This guide will delve into the intricate aspects of secondary NPH, providing an exhaustive resource for clinicians and researchers.

Technical Specifications / Mechanisms: Etiology and Pathophysiology

The fundamental issue in NPH, whether primary or secondary, lies in the disruption of CSF circulation and absorption. CSF is produced by the choroid plexus within the ventricles, circulates through the ventricular system and the subarachnoid space, and is primarily absorbed into the venous system via the arachnoid granulations. In secondary NPH, an underlying condition interferes with one or more of these stages, leading to a relative imbalance between CSF production and absorption.

Etiology of Secondary NPH

The causes of secondary NPH are diverse and can be broadly categorized:

• Subarachnoid Hemorrhage (SAH): This is one of the most common and well-established causes of secondary NPH. Blood in the subarachnoid space can obstruct the arachnoid granulations, impairing CSF absorption. It can also lead to inflammation and fibrosis, further hindering CSF flow.

  • Aneurysmal SAH: Rupture of a cerebral aneurysm.
  • Arteriovenous Malformation (AVM) Rupture: Bleeding from an AVM.
  • Traumatic SAH: Though less common to cause chronic NPH, severe head trauma can lead to SAH and subsequent hydrocephalus.

• Meningitis and CNS Infections: Inflammation of the meninges, particularly chronic or recurrent infections, can lead to adhesions and scarring within the subarachnoid space. This fibrosis can obstruct CSF pathways and absorption.

  • Bacterial Meningitis: Especially if treated late or inadequately.
  • Tuberculous Meningitis: A significant cause of communicating hydrocephalus and NPH in endemic regions.
  • Fungal Meningitis: Cryptococcal or candidal meningitis.
  • Viral Meningitis: Less common, but can contribute in some cases.

• Neoplasms (Brain Tumors): Tumors, particularly those located in the posterior fossa, cerebellopontine angle, or suprasellar regions, can directly obstruct CSF flow. Even if not directly compressing ventricles, tumors can cause leptomeningeal carcinomatosis, leading to diffuse subarachnoid involvement and impaired absorption.

  • Primary Brain Tumors: Gliomas, meningiomas, medulloblastomas.
  • Metastatic Tumors: Lung, breast, melanoma, etc.
  • Leptomeningeal Metastases: Dissemination of cancer cells within the CSF.

• Head Trauma: Severe traumatic brain injury (TBI), especially with associated SAH or diffuse axonal injury, can lead to chronic hydrocephalus. The mechanisms are similar to SAH, involving inflammation, scarring, and potential obstruction of CSF pathways.

• Intracranial Surgery: Surgical interventions, particularly those involving the posterior fossa or the basal cisterns, can lead to adhesions and scarring, disrupting CSF flow and absorption.

  • Tumor Resection: Especially in the posterior fossa.
  • Aneurysm Clipping/Coiling: Can sometimes be complicated by SAH or inflammatory responses.
  • Shunt Placement Complications: While shunts are treatments for hydrocephalus, prior surgeries or revisions can sometimes contribute to secondary NPH development.

• Other Inflammatory Conditions:

  • Sarcoidosis: Neurosarcoidosis can involve the meninges and lead to hydrocephalus.
  • Vasculitis: Inflammatory conditions affecting the blood vessels of the brain can lead to meningeal thickening and CSF flow abnormalities.

Pathophysiology of Ventricular Enlargement and Neurological Symptoms

In secondary NPH, the insult triggers a cascade of events:

1. Obstruction of CSF Absorption/Flow: The primary mechanism is the impairment of CSF reabsorption at the arachnoid granulations or obstruction of CSF pathways within the ventricles or subarachnoid space.
2. Ventricular Enlargement: As CSF production continues unabated while absorption is compromised, CSF accumulates within the ventricles.
3. Increased Ventricular Pressure (Transient): Initially, the increased CSF volume may lead to transient elevations in ICP. However, the brain adapts by increasing its compliance, and the ICP often normalizes or fluctuates within the normal range. This is a key feature distinguishing NPH from acute hydrocephalus.
4. Ventricular Expansion and White Matter Compression: Chronic ventricular enlargement exerts pressure on the surrounding brain parenchyma, particularly the periventricular white matter. This compression can lead to:
   • Axonal Shearing: The white matter tracts, especially those connecting different brain regions (e.g., corticospinal tracts, corpus callosum fibers), are vulnerable to stretching and shearing.
   • Ischemia: Reduced blood flow to the compressed white matter can lead to ischemic injury.
   • Demyelination: Chronic pressure and ischemia can result in demyelination of these vital pathways.
5. Disruption of Neurotransmitter Systems: The periventricular white matter is rich in dopaminergic and cholinergic pathways. Compression and ischemia can disrupt these neurotransmitter systems, contributing to the characteristic triad of NPH symptoms.

This chronic, low-grade pressure and disruption of white matter tracts, rather than acute high ICP, are thought to underpin the progressive neurological dysfunction seen in NPH.

Clinical Indications & Usage: Standard Presentation

The diagnosis of secondary NPH is primarily clinical, supported by imaging and CSF studies. The hallmark presentation is the triad of:

1. Gait Disturbance: This is often the earliest and most prominent symptom.

   • Magnetic Gait: Feet appear to be stuck to the floor; shuffling steps.
   • Short Stride Length: Small, hesitant steps.
   • Wide Base of Support: Difficulty maintaining balance.
   • Difficulty Initiating Gait: Hesitation before starting to walk.
   • Unsteadiness and Falls: Increased risk of falling, particularly backwards.
   • Slowed Walking Speed: Overall reduction in mobility.

2. Cognitive Impairment: This is typically mild to moderate and often affects executive functions.

   • Apathy and Lack of Motivation: Reduced interest and engagement.
   • Slowed Processing Speed: Difficulty with thinking and problem-solving.
   • Impaired Executive Functions: Problems with planning, organization, abstract thinking, and decision-making.
   • Memory Deficits: More pronounced in recall than recognition, often related to slowed processing.
   • Attention and Concentration Difficulties: Easily distracted.
   • Behavioral Changes: Irritability, depression, or emotional lability.
   • In severe cases: Can progress to a state resembling dementia.

3. Urinary Incontinence: This symptom often appears later than gait disturbance and cognitive changes, but can be a significant cause of morbidity.

   • Urgency: Sudden, overwhelming urge to urinate.
   • Frequency: Needing to urinate more often than usual.
   • Incontinence: Leakage of urine, often starting as stress incontinence and progressing to urge incontinence.
   • Nocturia: Waking up at night to urinate.

Clinical Staging/Grading

While formal, universally accepted staging systems for NPH are less common than for other neurological conditions, severity can be assessed using scales that evaluate the impact of the symptoms on daily living. The Modified Rankin Scale (mRS) and the NPH Symptom Scale (NPH-SS) are frequently used.

• NPH Symptom Scale (NPH-SS): This scale quantifies the severity of the three core NPH symptoms (gait, cognition, and urinary function) on a scale of 0-3 for each symptom, with a total score ranging from 0 (asymptomatic) to 9 (severely affected).

  • Mild: NPH-SS 0-3
  • Moderate: NPH-SS 4-6
  • Severe: NPH-SS 7-9

• Modified Rankin Scale (mRS): This scale assesses functional independence.

  • mRS 0-1: Independent, no significant disability.
  • mRS 2-3: Mild to moderate disability, requires some assistance.
  • mRS 4-5: Severe disability, dependent on others.

The presence of these symptoms, particularly in a patient with a known history of SAH, meningitis, head trauma, or intracranial surgery, strongly suggests secondary NPH.

Differential Diagnosis

The clinical presentation of NPH can overlap with other neurological conditions, necessitating a thorough differential diagnosis. Key considerations include:

• Idiopathic Parkinson's Disease (PD) and Parkinsonian Syndromes: Gait disturbance, apathy, and slowed mentation can mimic NPH. However, PD typically has prominent resting tremor and rigidity, and the gait disturbance may differ (e.g., festination without the magnetic quality). PD patients usually don't have significant urinary incontinence unless late-stage or with other comorbidities.
• Alzheimer's Disease (AD) and Other Dementias: Cognitive impairment is the primary feature of AD. While NPH patients have cognitive deficits, the gait disturbance and urinary incontinence are usually more prominent or occur earlier than in typical AD. Memory loss is often more profound in AD.
• Vascular Dementia (VaD): Cognitive deficits and gait abnormalities can occur in VaD due to cerebrovascular disease. However, VaD often has a stepwise decline in function and a history of vascular risk factors (hypertension, diabetes, stroke). The characteristic ventricular enlargement of NPH may be absent or less pronounced.
• Frontotemporal Dementia (FTD): Behavioral changes and executive dysfunction are prominent in FTD. However, gait abnormalities and urinary incontinence are less common early features.
• Spinal Stenosis: Lumbar spinal stenosis can cause leg weakness, pain, and difficulty walking, mimicking the gait disturbance of NPH. However, spinal stenosis typically doesn't involve significant cognitive impairment or urinary incontinence unless there's concomitant cauda equina involvement.
• Normal Aging: Mild gait slowing, cognitive changes, and urinary urgency can occur with normal aging. However, the severity and progression of symptoms in NPH are typically more pronounced.
• Depression: Apathy, slowed psychomotor activity, and cognitive complaints can overlap with NPH. However, depression typically lacks the characteristic gait disturbance and urinary incontinence.

Key Diagnostic Tests

A multidisciplinary approach involving neurology, neurosurgery, and neuroradiology is essential for diagnosing secondary NPH.

1. Neuroimaging

• Magnetic Resonance Imaging (MRI): This is the gold standard for visualizing the ventricular system and identifying potential underlying causes of secondary NPH.

  • Ventricular Enlargement: Prominent enlargement of the lateral and third ventricles, disproportionate to the degree of cerebral atrophy. This is often described as "ex vacuo" enlargement, but in NPH, it's due to CSF accumulation.
  • Periventricular White Matter Changes (Edema/Ischemia): T2-weighted and FLAIR sequences often reveal increased signal intensity in the periventricular white matter, indicative of edema or chronic ischemia. This is a crucial finding.
  • Aqueductal Stenosis/Obstruction: While classic NPH is communicating, secondary NPH can sometimes be associated with partial or intermittent obstruction at the aqueduct of Sylvius, especially if caused by tumors or inflammation.
  • Evidence of Underlying Cause: MRI can reveal signs of SAH (blood products), meningeal enhancement (inflammation/infection), tumors, or post-surgical changes.
  • Callosal Angle: A reduced callosal angle (<90 degrees) on coronal views can suggest increased pressure from ventricular enlargement.
  • CSF Flow Studies (Phase-Contrast MRI): Can demonstrate impaired CSF flow through the aqueduct or at the basal cisterns, though interpretation can be complex.

• Computed Tomography (CT) Scan: Less sensitive than MRI for subtle white matter changes but can be useful for initial assessment, detecting gross ventricular enlargement, SAH, or large tumors.

2. Cerebrospinal Fluid (CSF) Analysis

• Lumbar Puncture (LP) with CSF Withdrawal (Therapeutic Tap Test): This is a critical diagnostic maneuver. A significant volume of CSF (e.g., 30-50 mL) is removed, and the patient's neurological status is assessed before and after the procedure.

  • Positive Response: A significant improvement in gait, cognition, or urinary symptoms lasting for at least 24-48 hours after the LP suggests NPH. This is a strong indicator for shunt surgery.
  • Negative Response: Lack of improvement suggests NPH is less likely, or the underlying cause may be different.
  • CSF Composition: Routine CSF analysis (cell count, protein, glucose) is typically normal in NPH but can reveal evidence of prior meningitis (elevated protein, pleocytosis) or malignancy (cytology).

• Intracranial Pressure Monitoring (ICP Monitoring): While not routinely performed for diagnosis, continuous ICP monitoring can sometimes be used in equivocal cases to document the absence of sustained elevated ICP or to demonstrate transient pressure elevations.

3. Neuropsychological Testing

• Detailed Cognitive Assessment: A comprehensive neuropsychological battery is essential to objectively quantify cognitive deficits, particularly in executive functions, memory, and attention. This helps establish a baseline and assess the response to treatment.

4. Gait Analysis

• Objective Gait Assessment: While clinical observation is important, objective measures like gait speed, stride length, and sway can be quantified using specialized equipment (e.g., GAITRite system) to provide a more precise assessment of gait impairment and its improvement after interventions.

Long-Term Prognosis

The long-term prognosis for secondary NPH is variable and depends heavily on the underlying etiology, the severity of neurological deficits at diagnosis, and the response to treatment.

• Untreated NPH: Without treatment, NPH is typically a progressive condition. Gait disturbance often leads to severe disability and increased risk of falls and fractures. Cognitive decline can progress to dementia, and urinary incontinence can lead to social isolation and increased risk of urinary tract infections. The prognosis is generally poor, with significant morbidity and reduced quality of life.

• Shunt Surgery: For selected patients who demonstrate a positive response to CSF withdrawal, surgical CSF shunting (typically a ventriculoperitoneal shunt) is the primary treatment.

  • Potential for Improvement: Shunt surgery can lead to significant improvement in gait, cognitive function, and urinary symptoms in a substantial proportion of patients. The improvement is often most pronounced in gait disturbances.
  • Variability of Response: Not all patients benefit from shunting. Factors influencing response include the duration and severity of symptoms, the underlying etiology of NPH, and the presence of significant irreversible brain damage.
  • Complications of Shunting: Shunt surgery carries risks, including infection, shunt malfunction (blockage, over-drainage, under-drainage), intracranial hemorrhage, and abdominal complications. These complications can necessitate further surgeries and can impact long-term outcomes.
  • Long-Term Management: Patients with shunts require lifelong monitoring for shunt function and potential complications.

• Prognosis Based on Etiology:

  • Post-SAH NPH: Prognosis can be good if treated early, but the underlying vascular insult can also contribute to long-term neurological deficits.
  • Post-Infectious NPH: Prognosis can be more guarded due to potential for ongoing inflammation or scarring.
  • Post-Traumatic NPH: Prognosis is often influenced by the severity of the initial brain injury.

In summary, while secondary NPH can be a debilitating condition, early and accurate diagnosis, coupled with appropriate management, offers the potential for significant functional recovery and improved quality of life for many patients. However, a realistic understanding of the potential for improvement and the risks associated with treatment is crucial.

Frequently Asked Questions (FAQ)

1. What is the difference between primary (idiopathic) NPH and secondary NPH?

Primary NPH is diagnosed when no specific underlying cause for the hydrocephalus can be identified. Secondary NPH, conversely, is NPH that develops as a consequence of a known insult or disease process, such as subarachnoid hemorrhage, meningitis, head trauma, or intracranial surgery.

2. How common is secondary NPH?

While exact prevalence figures are difficult to ascertain, secondary NPH accounts for a significant proportion of all NPH cases. Post-subarachnoid hemorrhage NPH is particularly well-recognized.

3. Can secondary NPH be cured?

"Cure" is a strong term. For many patients with secondary NPH, CSF shunting can significantly alleviate or even resolve the symptoms, leading to a substantial improvement in quality of life. However, the underlying cause may persist, and the brain damage may not be fully reversible. The goal is often symptom management and functional recovery rather than a complete eradication of the condition's root cause.

4. What are the most common causes of secondary NPH?

The most frequently identified causes include prior subarachnoid hemorrhage (especially from aneurysmal rupture), bacterial or tuberculous meningitis, severe head trauma, and complications from intracranial surgery.

5. How is secondary NPH diagnosed?

Diagnosis relies on a combination of clinical presentation (the triad of gait disturbance, cognitive impairment, and urinary incontinence), neuroimaging (MRI to show ventricular enlargement and periventricular white matter changes), and importantly, a positive response to a therapeutic lumbar puncture (CSF withdrawal).

6. Does everyone with a history of SAH or meningitis develop NPH?

No, not everyone who experiences these events will develop NPH. The risk depends on the severity of the hemorrhage or inflammation, the extent of damage to the subarachnoid space and arachnoid granulations, and individual factors.

7. Is gait disturbance always the first symptom of secondary NPH?

While gait disturbance is often the earliest and most prominent symptom, the order can vary. Some patients may experience cognitive changes or urinary symptoms first, though this is less common.

8. What is the role of the "tap test" (CSF withdrawal) in diagnosing secondary NPH?

The tap test is a crucial diagnostic tool. A significant and sustained improvement in neurological symptoms (particularly gait) after removing a substantial amount of CSF strongly supports the diagnosis of NPH and predicts a better response to shunt surgery.

9. What happens if secondary NPH is left untreated?

Untreated secondary NPH is typically progressive. Patients often experience worsening gait instability leading to falls, increasing cognitive decline, and severe urinary incontinence. This significantly impacts independence and quality of life, and can lead to institutionalization.

10. What are the long-term risks associated with shunt surgery for secondary NPH?

Shunt surgery, while effective for many, carries risks including infection, shunt malfunction (blockage, over-drainage, under-drainage), intracranial hemorrhage, and abdominal complications. These risks can necessitate revision surgeries and ongoing medical management.

11. Can secondary NPH improve spontaneously?

Spontaneous resolution of secondary NPH is rare. The underlying pathological processes that lead to CSF circulation abnormalities are usually chronic and progressive, requiring intervention.

12. How does secondary NPH affect cognitive function?

Secondary NPH typically affects executive functions (planning, organization, problem-solving), attention, and processing speed. Memory can also be affected, but often less severely than in conditions like Alzheimer's disease. Apathy and slowed thinking are common.

13. What is the prognosis after shunt surgery for secondary NPH?

The prognosis is variable. Many patients experience significant improvement, particularly in gait. Cognitive and urinary symptoms may improve to a lesser extent. However, some patients may not respond well to surgery, and long-term outcomes depend on factors like the original cause, the extent of brain damage, and shunt-related complications.

14. Can secondary NPH be prevented?

Prevention focuses on managing the underlying causes. For example, prompt and effective treatment of meningitis or aneurysmal SAH can reduce the risk of developing secondary NPH. However, in cases of severe trauma or certain types of infections, prevention may not be possible.

15. What is the role of dopamine in NPH symptoms?

While the exact mechanisms are still being researched, disruption of dopaminergic pathways in the periventricular white matter is thought to contribute to the gait disturbances and apathy seen in NPH. This is why some patients may show a transient, mild improvement with dopaminergic medications, though this is not a substitute for shunting.